DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 93 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

AksharChem India Limited — Certificate under SEBI (Depositories and Participants) Regulations, 2018

NSE 1 hr ago·7 Oct 2026, 5:19 am

Aksharchem India

AksharChem India Limited has informed stock exchanges that it has received a certificate under the SEBI (Depositories and Participants) Regulations, 2018. This regulatory compliance confirms that the company's shares are eligible for dematerialization and electronic settlement.

This development is a standard corporate disclosure that ensures the stock meets the necessary regulatory requirements for trading in electronic form. For investors, it signifies that the company's shares are fully compliant with market standards, facilitating smoother transactions and settlement processes.

Investors should monitor the company's future announcements for any other significant regulatory updates or business developments that might impact the stock's performance.